Häftad, Engelska, 2027

Epigenetics and miRNA in Neurodegenerative Diseases

From Molecular Mechanisms to Clinical Applications

Av Lance R. McMahon, Dharmendra Kumar Khatri, Balachandar Vellingiri

2687 kr

Kommande

Beskrivning

Epigenetics and miRNA in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications explores the crucial role of epigenetic modifications and microRNAs in the onset, progression, and treatment of neurodegenerative disorders such as Alzheimer’s, Parkinson’s, ALS, and Huntington’s disease. This comprehensive book bridges cutting-edge molecular research with real-world clinical applications, covering biomarker discovery, novel therapeutics, gene editing, and AI-driven bioinformatics. With clear explanations, case studies, and future perspectives, it serves as an essential resource for researchers, clinicians, and biotech professionals working toward innovative solutions for neurodegenerative disease diagnosis and treatment

Integrates perspectives from neuroscience, molecular biology, clinical medicine, and bioinformatics
Covers fundamental molecular mechanisms, disease specific applications, and translational research, appealing to both researchers and clinicians
Provides practical examples of epigenetic and miRNA research as applied to neurodegenerative diseases, aiding in real-world implementation

Produktinformation

Utgivningsdatum: 2027-04-01
Mått: 216 x 276 x undefined mm
Vikt: 450 g
Format: Häftad
Språk: Engelska
Antal sidor: 325
Förlag: Elsevier Science
ISBN: 9780443448454

Utforska kategorier

Biovetenskap

Mer om författaren

Lance R. McMahon, Ph.D., serves as the Executive Vice President for Research and Innovation at Texas Tech University Health Sciences Center. In his position, Dr. McMahon will serve as chair of the Research Council. Additionally, he has a faculty appointment in the Jerry H. Hodge School of Pharmacy. Dr. Dharmendra Kumar Khatri is an Associate Professor in the Department of Pharmacology, NIMS Institute of Pharmacy at NIMS University Rajasthan, Jaipur, India. Dr. Balachandar Vellingiri currently is investigating various neurological diseases and developing human induced pluripotent stem cells (HiPSCs). Exploring the cutting-edge molecular, cellular, and translational neuroscience approaches, he aims to unravel disease mechanisms, identify therapeutic targets, and develop innovative interventions to slow or reverse neurological diseases. His expertise is on several techniques such as molecular cytogenetics, pathway analysis, and techniques in developing HiPSCs and Brain organoids, especially for neurological diseases.

Betyg & recensioner

0 recensioner

Inga recensioner tillgängliga.